Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zimmer Biomet : To Pay Q3 Dividend

09/03/2021 | 07:51am EDT


ę MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
10/07ZIMMER BIOMET : Announces Webcast and Conference Call of Third Quarter 2021 Financial Resu..
PR
10/05ZIMMER BIOMET : Barclays Cuts Price Target on Zimmer Biomet to $186 From $210, Keeps Overw..
MT
09/29ZIMMER BIOMET HOLDINGS, INC. : Ex-dividend day for
FA
09/28WALL STREET STOCK EXCHANGE : Is inflation still transitionary?
09/28ANALYST RECOMMENDATIONS : 888, Chesapeake Energy, Conocophillips, Marathon Oil, Playtech....
09/27ZIMMER BIOMET : Needham Lowers PT for Zimmer Biomet Holdings to $187 From $202 Given Impac..
MT
09/15ZIMMER BIOMET : Announces Key Additions to 'NewCo' Leadership Team, Transaction to Form Ne..
AQ
09/14ZIMMER BIOMET : Names Finance Chief for Company Spin-Off
MT
09/14ZIMMER BIOMET : Announces Key Additions to "NewCo" Leadership Team; Transaction to Form Ne..
PR
09/14Zimmer Biomet Holdings, Inc. Announces Executive Changes
CI
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 8 061 M - -
Net income 2021 967 M - -
Net Debt 2021 6 377 M - -
P/E ratio 2021 33,2x
Yield 2021 0,64%
Capitalization 31 291 M 31 291 M -
EV / Sales 2021 4,67x
EV / Sales 2022 4,26x
Nbr of Employees 20 000
Free-Float 66,8%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 30
Last Close Price 149,83 $
Average target price 184,67 $
Spread / Average Target 23,3%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-2.76%31 291
ABBOTT LABORATORIES17.02%227 151
MEDTRONIC PLC5.90%166 948
BECTON, DICKINSON AND COMPANY-1.55%70 749
HOYA CORPORATION21.16%55 803
DEXCOM, INC.52.99%54 725